Literature DB >> 17122234

The effect of electroencephalogram-targeted high- and low-dose propofol infusion on histopathological damage after traumatic brain injury in the rat.

Eva Eberspächer1, Kerstin Heimann, Regina Hollweck, Christian Werner, Gerhard Schneider, Kristin Engelhard.   

Abstract

BACKGROUND: Propofol is commonly used to sedate patients after traumatic brain injury. However, the dose-dependent neuroprotective effects of propofol after head trauma are unknown. We compared histopathological damage after 6 h of electroencephalogram-targeted high- and low-dose propofol infusion in rats subjected to controlled cortical impact (CCI).
METHODS: Animals were randomly assigned to CCI/propofol with electroencephalogram burst-suppression-ratio 1%-5% (CCI/lowprop), CCI/propofol with burst-suppression-ratio 30%-40% (CCI/highprop), control group CCI/1.0 vol % halothane (CCI/halo), or sham group with halothane anesthesia (SHAM/halo). Brain slices were stained with kresyl violet (KV) and hematoxylin/eosin (HE) to evaluate lesion volume, number of eosinophilic cells, and activation of caspase-3 in the hippocampus.
RESULTS: Lesion volume (mm3) and number of eosinophilic cells in the hippocampus did not differ significantly [lesion volumes: CCI/lowprop 31.55 +/- 14.66 (KV) and 53.77 +/- 8.62 (HE); CCI/highprop 33.81 +/- 10.57 (KV) and 52.30 +/- 11.55 (HE); CCI/halo 36.42 +/- 17.06 (KV) and 57.95 +/- 8.49 (HE)]. Activation of caspase-3 occurred in the ipsilateral hippocampus in all CCI-groups.
CONCLUSION: Despite different levels of cortical neuronal function, there were no relevant differences in the short-term histopathological damage. These results challenge the view that the neuroprotective effect of propofol relates to the suppression of cerebral metabolic demand.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122234     DOI: 10.1213/01.ane.0000247803.30582.2d

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

Review 1.  Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side.

Authors:  Alice Jacquens; Edward J Needham; Elisa R Zanier; Vincent Degos; Pierre Gressens; David Menon
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

2.  Propofol: neuroprotection in an in vitro model of traumatic brain injury.

Authors:  Jan Rossaint; Rolf Rossaint; Joachim Weis; Michael Fries; Steffen Rex; Mark Coburn
Journal:  Crit Care       Date:  2009-04-27       Impact factor: 9.097

3.  Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.

Authors:  Leonardo Lorente; María M Martín; Mónica Argueso; Luis Ramos; Jordi Solé-Violán; Marta Riaño-Ruiz; Alejandro Jiménez; Juan M Borreguero-León
Journal:  BMC Neurol       Date:  2015-11-06       Impact factor: 2.474

Review 4.  Biomarkers Associated with the Outcome of Traumatic Brain Injury Patients.

Authors:  Leonardo Lorente
Journal:  Brain Sci       Date:  2017-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.